06.03.2013 Views

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />

cap sules 12%<br />

liq uids 3%<br />

med i cal dress ings 1%<br />

NEW ZEALAND<br />

CIBA VI SION<br />

Full Name: CIBA Vi sion Aus tra lia Pty Lim ited<br />

Street Ad dress: 6-8 MacKelvie Street, Grey<br />

Lynn 1002, Auckland<br />

Tel: +64 9 820-3728<br />

Fax: +64 9 820-3775<br />

Home Page: www.cibavision.com.au<br />

NOVARTIS<br />

Full Name: Novartis New Zea land Ltd<br />

Postal Ad dress: Pri vate Bag 47909, Ponsonby,<br />

1034<br />

Street Ad dress: 6-8 MacKelvie Street, Grey<br />

Lynn 1002, Auckland<br />

Tel: +64 9 361-8100<br />

Fax: +64 9 361-8181<br />

De scrip tion: Re searcher, im porter, ex porter,<br />

dis trib u tor, pro moter, sales/detailer. Prod uct<br />

ranges in clude: phar ma ceu ti cal prod ucts<br />

(branded, pre scrip tion, non-pre scrip tion), hos pi -<br />

tal pharmaceuticals, di etetic/nu tri tional prod ucts,<br />

oph thal mic prod ucts, vet er i nary pharmaceuticals.<br />

Es tab lished 1997. 22 phar ma ceu ti cal em ploy ees<br />

in 2008. Di vi sions in clude: Novartis Con sumer<br />

Health. Pharmaceuticals; Con sumer Health;<br />

Animal Health; Ciba Vision New Zealand.<br />

Rep re sen ta tives/De tail ers (Pharm, Num -<br />

ber): 11-20 (2008)<br />

Con tacts (Pharm): Chair man: Nuchanard<br />

Pinyapong; Mar ket Re search: Adam Gaskill; Gen -<br />

eral Con tact: Adam Gaskill<br />

Sub sid iary of: Novartis, Swit zer land (100%)<br />

Phar ma ceu ti cal Sales: US$ 35-40 mil lion<br />

Prod ucts (% of Sales by Lead ing 5): 70-75%<br />

Ther a peu tic Classes (% of Sales by Lead ing<br />

5): 75-80%<br />

Dose Forms (% of Sales by Lead ing 5):<br />

90-95%<br />

Prin ci pal Prod ucts:<br />

GLIVEC (antineoplastic other)<br />

SANDIMMUN (immunosuppressive agent)<br />

SANDOSTATIN LAR (hor mone hy po tha lamic)<br />

CLOZARIL (antipsychotic)<br />

TEGRETOL (antiepileptic)<br />

Ther a peu tic Range:<br />

antineoplastics 32%<br />

immunosuppressive agents 16%<br />

hor mones pi tu itary and hy po tha lamic 12%<br />

psycholeptics 10%<br />

antiepileptics 6%<br />

Lead ing Dose Forms:<br />

cap sules 51%<br />

tab lets 17%<br />

pre-filled sy ringes/pens 10%<br />

coated tab lets 9%<br />

am poules 3%<br />

NIGERIA<br />

NOVARTIS<br />

Full Name: Novartis Pharma Ser vices AG<br />

Postal Ad dress: PO Box 4310, Lagos<br />

Street Ad dress: 387 Agege Mo tor Road, Mushin,<br />

Lagos<br />

Tel: +234 1 4528535<br />

Fax: +234 1 4523500<br />

De scrip tion: De vel oper, pro moter,<br />

sales/detailer. De vel ops, pro motes, sells/de tails<br />

for other com pa nies. Prod uct ranges in clude:<br />

phar ma ceu ti cal prod ucts (pre scrip tion), oph thal -<br />

mic prod ucts. 25 phar ma ceu ti cal employees in<br />

2008.<br />

Rep re sen ta tives/De tail ers (Pharm, Num -<br />

ber): 16 (2008)<br />

Con tacts (Pharm): Chair man: Chris Ufomadu;<br />

Com mer cial Op er a tions: Olusegun Omolambe<br />

NORWAY<br />

CIBA VI SION<br />

Full Name: Ciba Vi sion Norge A/S<br />

Postal Ad dress: Postboks 24, N-3602<br />

Kongsberg<br />

Street Ad dress: Dyrmyrgaten 47, N-3611<br />

Kongsberg<br />

Tel: +47 32 77 11 22<br />

Fax: +47 32 77 11 55<br />

Home Page: www.cibavision.no<br />

Phar ma ceu ti cal Sales: US$ 5-6 mil lion<br />

Prod ucts (% of Sales by Lead ing 5): 80-85%<br />

Ther a peu tic Classes (% of Sales by Lead ing<br />

5): n.a.<br />

Dose Forms (% of Sales by Lead ing 5): n.a.<br />

Prin ci pal Prod ucts:<br />

SPERSADEX M/KLORAM (ophthalmological<br />

anti-in flam ma tory/anti-in fec tive com bi na tion)<br />

© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 191

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!